|
New Tools and Methods |
Databases and Libraries |
High-Risk |
High Throughput Analyses |
Translational |
Population Science |
Training |
CURRENT PROGRAMS |
|
|
|
|
|
|
|
Bioinformatics and Computational Biology |
|
|
|
|
|
|
|
Bridging Interventional Development
Gaps (BrIDGs) |
|
|
|
|
|
|
|
Building Blocks, Biological Pathways and Networks |
|
|
|
|
|
|
|
Epigenomics |
|
|
|
|
|
|
|
Extracellular RNA Communication |
|
|
|
|
|
|
|
Genotype-Tissue Expression (GTEx) |
|
|
|
|
|
|
|
Global Health |
|
|
|
|
|
|
|
Gulf Oil Spill |
|
|
|
|
|
|
|
HCS Research Collaboratory |
|
|
|
|
|
|
|
Health Economics |
|
|
|
|
|
|
|
HIGH-RISK RESEARCH: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Human Microbiome Project (HMP) |
|
|
|
|
|
|
|
Increasing the Diversity of the NIH-Funded Workforce |
|
|
|
|
|
|
|
Knock out Mouse Phenotyping (KOMP2) |
|
|
|
|
|
|
|
Library of Integrated Network-Based Cellular Signatures (LINCS) |
|
|
|
|
|
|
|
Metabolomics |
|
|
|
|
|
|
|
Molecular Libraries and Imaging |
|
|
|
|
|
|
|
Nanomedicine |
|
|
|
|
|
|
|
NIH Center for Regenerative Medicine (NIH CRM) |
|
|
|
|
|
|
|
NIH Medical Research Scholars Program |
|
|
|
|
|
|
|
PROMIS: Patient-Reported Outcomes Measurement Information System |
The Patient-Reported Outcomes Measurement Information System (PROMIS) program is creating new paradigms for how clinical research information is collected, used, and reported. PROMIS addresses a need in the clinical research community for a rigorously tested patient reported outcome (PRO) measurement tool that utilizes recent advances in information technology, psychometrics, and qualitative, cognitive, and health survey research to measure PROs such as pain, fatigue, physical functioning, emotional distress, and social role participation that have a major impact on quality-of-life across a variety of chronic diseases. |
|
|
|
|
|
|
Protein Capture Reagents |
|
|
|
|
|
|
|
Regulatory Science |
The NIH, together with the U.S. Food and Drug Administration (FDA), are supporting an initiative in Regulatory Science to generate new knowledge and tools for assessing experimental therapies, preventives, and diagnostics. The Regulatory Science program fosters the development, evaluation and availability of new or improved tools, methods, standards, and applied science that support a better understanding and improved evaluation of product safety, quality, effectiveness, and manufacturing throughput the product life cycle. Advances in this area depend on the incorporation of cutting-edge science and evidence-based knowledge into regulatory decision making. |
|
|
|
|
|
|
Science of Behavior Change |
|
|
|
|
|
|
|
Single Cell Analysis |
|
|
|
|
|
|
|
Strengthening the Biomedical Research Workforce |
|
|
|
|
|
|
|
Structural Biology |
|
|
|
|
|
|
|
Undiagnosed Diseases |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EXPORTED PROGRAMS |
|
|
|
|
|
|
|
Clinical Research Policy Analysis and Coordination (CRPac) |
|
|
|
|
|
|
|
Clinical and Translational Science Awards (CTSAs) |
|
|
|
|
|
|
|
Interdisciplinary Research (IR) |
|
|
|
|
|
|
|
National Electronics Clinical Trials and Research (NECTAR) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|